Addiction Medicine

Subutex and Suboxone for Addiction

Buprenorphin comes in a formulation that can be taken via  patch thorugh the skin or under the tongue. In October 2002, the Food and Drug Administration (FDA) approved buprenorphine monotherapy product, Subutex®, and a buprenorphine/naloxone combination product, Suboxone®, for use in narcotic addiction treatment. IT saturates narcotic receptors and prevents a “high”. The combination product is designed to decrease the potential for abuse by

Read more

Antabuse, or disulfiram, is approved for the treatment of alcohol abuse and alcohol dependence by the U.S. Food and Drug Administration. When alcohol is consumed it is metabolized by the body into acetaldehyde, and then into acetic acid, which is harmless. Antabuse interferes with this step, causing a buildup of acetaldehyde As a result, there is a build up of acetaldehyde five or 10 times greater than normally occurs when someone drinks alcohol.

Read more
Inpatient Versus Outpatient Alcohol Rehab

There are many similarities between inpatient and outpatient alcohol rehab programs. Both types of treatment programs provide direction and guidance to the patients and their families to educate them about what alcoholism is and how to set and meet appropriate goals for treatment and recovery. Inpatient therapy involves a 24/7 stay in a residential treatment facility that is isolated from the outside world. The goal is to provide a setting that keeps

Read more